The Hi-tACS on Cognitive Function in Patients With Schizophrenia
ConditionSchizophrenia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSir Run Run Shaw Hospital
About this trial
This study is a double-blind, randomized, controlled intervention study aimed at exploring whether high-frequency transcranial alternating current stimulation (Hi-tACS) can improve cognitive impairment in patients with schizophrenia.
Eligibility criteria
Qualifiers
Meets the diagnostic criteria for schizophrenia according to DSM-5.
Age ≥ 18 years old.
Right-handed.
Willing to participate in this study and sign an informed consent form. If the participant is unable to read and sign the informed consent form due to lack of capacity, a legal guardian must act as a proxy during the informed consent process and sign the form.
Disqualifiers
Psychotic disorders caused by split affective disorder, bipolar disorder, intellectual disability, anxiety spectrum disorders, drugs, alcohol, and other psychoactive substances according to DSM-V diagnostic criteria.
Those with severe or unstable organic diseases, with a history of brain tumors or epilepsy.
Those who have received MECT or TMS treatment within 1 month before enrollment.
Skin integrity at the electrode placement site is compromised. Allergy to electrode gel or adhesive.
Trial design
Treatments tested in this trial
- high-frequency transcranial alternating current stimulation
- sham high-frequency transcranial alternating current stimulation
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Sir Run Run Shaw Hospital
Lead sponsor
Quzhou Third hospital
Collaborator
Taizhou Second People's Hospital
Collaborator
the Seventh Hospital of Shaoxing City
Collaborator
Source ClinicalTrials.gov